Cargando…

Efficacy and safety of interferon alpha therapy in children with chronic hepatitis B: A long-term follow-up cohort study from China

Interferon-alpha (IFN-α) is currently the preferred antiviral treatment for children with chronic hepatitis B (CHB) aged >1-year-old. However, the evidence regarding the exact efficacy and safety in the real world is not sufficient. This study aimed to investigate the efficacy of IFN-α therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yao, Ye, Yingzi, Ye, Lijing, Wang, Xiaohong, Yu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708814/ https://www.ncbi.nlm.nih.gov/pubmed/31393369 http://dx.doi.org/10.1097/MD.0000000000016683

Ejemplares similares

Liver histological reversibility of lamivudine in treatment-naïve children with chronic hepatitis B: a retrospective cohort study from a single center Shanghai China
por: Hu, Yao, et al.
Publicado: (2023)

Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea
por: Kim, Jie-Hyun, et al.
Publicado: (2006)

Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy
por: Alvarado-Castillo, Beatriz, et al.
Publicado: (2023)

Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors
por: Yan, Zehui, et al.
Publicado: (2012)

Predictors of Pegylated Interferon Alpha and Ribavirin Efficacy and Long-Term Assessment of Relapse in Patients With Chronic Hepatitis C: A One-Center Experience From China
por: Wu, Qin, et al.
Publicado: (2015)

Efficacy and Safety of Interferon-Alpha 2b for Patients with Hepatic Epithelioid Hemangioendothelioma: Outcomes of a Case-Series Analysis
por: Liu, Xiaolei, et al.
Publicado: (2021)

Exosomal Interferon‐Induced Transmembrane Protein 2 Transmitted to Dendritic Cells Inhibits Interferon Alpha Pathway Activation and Blocks Anti–Hepatitis B Virus Efficacy of Exogenous Interferon Alpha
por: Shi, Ying, et al.
Publicado: (2019)

Efficacy and Safety of Low-Dose Peginterferon Alpha-2a Plus Ribavirin on Chronic Hepatitis C
por: Yan, Zehui, et al.
Publicado: (2012)

Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis
por: Lund, Allan M., et al.
Publicado: (2018)

Long-term safety and efficacy of leadless pacemakers in the Dutch cohort
por: Breeman, K T N, et al.
Publicado: (2023)

An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study
por: Chon, Young Eun, et al.
Publicado: (2016)

Interferon-alpha responsible EPN3 regulates hepatitis B virus replication
por: Li, Xueqian, et al.
Publicado: (2022)

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
por: Zeng, Yan-Ming, et al.
Publicado: (2020)

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
por: Keshvari, Maryam, et al.
Publicado: (2014)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
por: Roade, Luisa, et al.
Publicado: (2021)

The Short- and Long-Term Safety and Efficacy Profile of Subtotal Cholecystectomy: A Single-Centre, Long-Term, Follow-Up Study
por: Bodla, Ahmed Salman, et al.
Publicado: (2023)

A long-term subacute sclerosing panencephalitis survivor treated with intraventricular interferon-alpha for 13 years
por: Kwak, Minsun, et al.
Publicado: (2019)

Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment
por: Giersch, Katja, et al.
Publicado: (2023)

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study
por: O'Connor, Paul, et al.
Publicado: (2016)

Interferon and Hepatitis B: Current and Future Perspectives
por: Ye, Jianyu, et al.
Publicado: (2021)

Long-Term Treatment Efficacy and Safety of Clevudine Therapy in Naïve Patients with Chronic Hepatitis B
por: Choung, Bum Su, et al.
Publicado: (2012)

The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B
por: He, Yi, et al.
Publicado: (2022)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Comparative efficacy and safety of antibody induction therapy for the treatment of kidney: a network meta-analysis
por: Shao, Mingjie, et al.
Publicado: (2017)

Long-term efficacy and safety of iloperidone: an update
por: Rado, Jeffrey T, et al.
Publicado: (2014)

The Efficacy of the Interferon Alpha/Beta Response versus Arboviruses Is Temperature Dependent
por: Lane, Whitney C., et al.
Publicado: (2018)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C
por: Dhillon, Sonu, et al.
Publicado: (2010)

Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C
por: Trien, Remi, et al.
Publicado: (2014)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication
por: Li, Jia, et al.
Publicado: (2022)

Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C
por: Wei, Lai, et al.
Publicado: (2019)

Cloning, expression and antiviral activity of mink alpha-interferons
por: Zhang, Hai-ling, et al.
Publicado: (2015)

Long-term Efficacy of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A 5-year Follow-up Study in China
por: Jiang, Lu-Lu, et al.
Publicado: (2015)

Efficacy, Safety, and Long-Term Follow-Up Results of EUS-Guided Transmural Drainage for Pancreatic Pseudocyst
por: Kato, Shin, et al.
Publicado: (2013)

Safety and Efficacy of Low-Level Laser Therapy in Autoimmune Thyroiditis: Long-Term Follow-Up Study
por: Höfling, Danilo Bianchini, et al.
Publicado: (2018)

Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223
por: Steingo, Brian, et al.
Publicado: (2020)

Comparison of safety, efficacy, and long-term follow-up between “one-step” and “step-up” approaches for infected pancreatic necrosis
por: Zheng, Zhi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7qmrjdni3onv0a8mc1clddvabv